| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 75 | 2019 | 9988 | 3.140 |
Why?
|
| Mesothelioma | 16 | 2014 | 806 | 1.830 |
Why?
|
| Lung Diseases, Interstitial | 15 | 2018 | 907 | 1.510 |
Why?
|
| Pleural Neoplasms | 12 | 2013 | 609 | 1.490 |
Why?
|
| Dyspnea | 20 | 2019 | 1352 | 1.450 |
Why?
|
| Diagnosis, Differential | 69 | 2019 | 12968 | 1.380 |
Why?
|
| Lung Diseases | 27 | 2016 | 1915 | 1.340 |
Why?
|
| Pleura | 8 | 2015 | 243 | 1.300 |
Why?
|
| Lung Neoplasms | 73 | 2019 | 13249 | 1.250 |
Why?
|
| Cryptogenic Organizing Pneumonia | 5 | 2007 | 28 | 1.040 |
Why?
|
| Tracheal Neoplasms | 6 | 2010 | 123 | 1.020 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2019 | 499 | 0.960 |
Why?
|
| Sarcoidosis | 6 | 2019 | 520 | 0.940 |
Why?
|
| Alveolitis, Extrinsic Allergic | 5 | 2019 | 62 | 0.920 |
Why?
|
| Pulmonary Fibrosis | 12 | 2013 | 507 | 0.860 |
Why?
|
| Pleural Effusion | 8 | 2015 | 343 | 0.810 |
Why?
|
| Pathology | 5 | 2008 | 270 | 0.810 |
Why?
|
| Tracheal Stenosis | 4 | 2013 | 226 | 0.770 |
Why?
|
| Actinomycosis | 2 | 2015 | 20 | 0.720 |
Why?
|
| Bronchiolitis Obliterans | 3 | 2016 | 212 | 0.710 |
Why?
|
| Biopsy | 29 | 2019 | 6775 | 0.670 |
Why?
|
| Radiography | 28 | 2016 | 6965 | 0.660 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2018 | 24 | 0.620 |
Why?
|
| Granuloma | 6 | 2009 | 328 | 0.570 |
Why?
|
| Pneumonia | 10 | 2011 | 2138 | 0.560 |
Why?
|
| Adenocarcinoma | 25 | 2016 | 6310 | 0.560 |
Why?
|
| Hemoptysis | 3 | 2002 | 152 | 0.560 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2017 | 53 | 0.560 |
Why?
|
| Pulmonary Blastoma | 3 | 2004 | 41 | 0.530 |
Why?
|
| Asbestosis | 5 | 2010 | 81 | 0.530 |
Why?
|
| Pasteurellaceae Infections | 1 | 2015 | 3 | 0.520 |
Why?
|
| Empyema | 1 | 2015 | 41 | 0.520 |
Why?
|
| Fatal Outcome | 15 | 2011 | 1833 | 0.510 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2016 | 79 | 0.510 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2014 | 103 | 0.500 |
Why?
|
| Necrobiotic Disorders | 1 | 2014 | 5 | 0.500 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 147 | 0.500 |
Why?
|
| Amiodarone | 2 | 2008 | 218 | 0.470 |
Why?
|
| Cytoskeletal Proteins | 4 | 2004 | 1344 | 0.470 |
Why?
|
| Asbestos | 8 | 2006 | 251 | 0.450 |
Why?
|
| Bronchial Diseases | 3 | 2011 | 151 | 0.450 |
Why?
|
| Thoracic Wall | 1 | 2015 | 199 | 0.440 |
Why?
|
| Lymph Nodes | 9 | 2016 | 3491 | 0.440 |
Why?
|
| Radiography, Thoracic | 10 | 2019 | 1295 | 0.440 |
Why?
|
| Lymphangioma | 2 | 2011 | 61 | 0.430 |
Why?
|
| BCG Vaccine | 1 | 2015 | 371 | 0.420 |
Why?
|
| Hypercalcemia | 1 | 2015 | 421 | 0.410 |
Why?
|
| Vasculitis | 7 | 2008 | 523 | 0.410 |
Why?
|
| Cell Nucleus | 7 | 2013 | 2909 | 0.410 |
Why?
|
| Carcinoma, Bronchogenic | 4 | 2000 | 86 | 0.400 |
Why?
|
| Pathology, Clinical | 6 | 2017 | 375 | 0.390 |
Why?
|
| Calcinosis | 3 | 2010 | 1478 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 32 | 2019 | 20483 | 0.390 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2008 | 784 | 0.390 |
Why?
|
| Respiratory Insufficiency | 6 | 2017 | 1228 | 0.380 |
Why?
|
| Lung Diseases, Fungal | 2 | 2008 | 125 | 0.380 |
Why?
|
| Tracheostomy | 1 | 2015 | 425 | 0.380 |
Why?
|
| Trachea | 6 | 2015 | 1082 | 0.380 |
Why?
|
| Polyomavirus Infections | 1 | 2013 | 195 | 0.370 |
Why?
|
| Paraproteinemias | 1 | 2013 | 246 | 0.370 |
Why?
|
| Pleural Diseases | 4 | 2010 | 137 | 0.370 |
Why?
|
| Humans | 202 | 2019 | 760276 | 0.360 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 438 | 0.360 |
Why?
|
| Male | 131 | 2019 | 359427 | 0.350 |
Why?
|
| Bronchial Neoplasms | 3 | 2006 | 110 | 0.350 |
Why?
|
| Fever | 8 | 2016 | 1618 | 0.350 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2009 | 20 | 0.340 |
Why?
|
| Tuberculosis, Miliary | 2 | 2015 | 13 | 0.340 |
Why?
|
| Trans-Activators | 3 | 2004 | 2861 | 0.340 |
Why?
|
| Renal Insufficiency | 2 | 2015 | 820 | 0.340 |
Why?
|
| Myositis | 1 | 2012 | 269 | 0.340 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 13 | 2016 | 5248 | 0.340 |
Why?
|
| Pulmonary Alveoli | 8 | 2013 | 653 | 0.330 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2012 | 1614 | 0.320 |
Why?
|
| Middle Aged | 97 | 2019 | 220179 | 0.320 |
Why?
|
| Histiocytosis, Langerhans-Cell | 3 | 2016 | 169 | 0.320 |
Why?
|
| DNA Adducts | 5 | 2012 | 94 | 0.320 |
Why?
|
| Giant Cell Arteritis | 3 | 2002 | 296 | 0.310 |
Why?
|
| Aged | 86 | 2019 | 169002 | 0.310 |
Why?
|
| Cysts | 5 | 2002 | 683 | 0.310 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 695 | 0.310 |
Why?
|
| Tomography, Optical Coherence | 8 | 2018 | 2877 | 0.310 |
Why?
|
| Immunohistochemistry | 19 | 2016 | 11064 | 0.310 |
Why?
|
| Hemangioma, Capillary | 2 | 2005 | 62 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2016 | 4024 | 0.300 |
Why?
|
| Histoplasmosis | 2 | 2002 | 63 | 0.300 |
Why?
|
| Telepathology | 3 | 2014 | 77 | 0.290 |
Why?
|
| Glomus Tumor | 1 | 2008 | 62 | 0.290 |
Why?
|
| Status Asthmaticus | 1 | 2007 | 22 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2015 | 2093 | 0.290 |
Why?
|
| Kidney | 5 | 2015 | 7071 | 0.290 |
Why?
|
| Inclusion Bodies | 1 | 2008 | 281 | 0.280 |
Why?
|
| Takayasu Arteritis | 2 | 2002 | 95 | 0.280 |
Why?
|
| Carcinoma, Large Cell | 3 | 2004 | 113 | 0.280 |
Why?
|
| Female | 118 | 2019 | 391024 | 0.280 |
Why?
|
| Cartilage Diseases | 1 | 2008 | 156 | 0.280 |
Why?
|
| Mediastinal Neoplasms | 1 | 2009 | 402 | 0.270 |
Why?
|
| Aspergillosis | 1 | 2008 | 243 | 0.260 |
Why?
|
| Adult | 85 | 2018 | 219843 | 0.260 |
Why?
|
| Crohn Disease | 2 | 2014 | 2275 | 0.250 |
Why?
|
| Pericarditis, Tuberculous | 1 | 2004 | 7 | 0.240 |
Why?
|
| Mutation | 18 | 2017 | 29951 | 0.240 |
Why?
|
| Cartilage | 1 | 2008 | 806 | 0.240 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 4 | 2007 | 88 | 0.240 |
Why?
|
| Pulmonary Alveolar Proteinosis | 2 | 2011 | 40 | 0.230 |
Why?
|
| Autopsy | 2 | 2006 | 1007 | 0.230 |
Why?
|
| Bronchoscopy | 4 | 2013 | 908 | 0.220 |
Why?
|
| Respiratory Function Tests | 6 | 2009 | 1684 | 0.220 |
Why?
|
| Pathology, Surgical | 3 | 2014 | 151 | 0.220 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2006 | 487 | 0.220 |
Why?
|
| Biotin | 1 | 2004 | 253 | 0.220 |
Why?
|
| Lymphatic Diseases | 2 | 2016 | 319 | 0.210 |
Why?
|
| Bronchi | 5 | 2018 | 848 | 0.210 |
Why?
|
| Brucella melitensis | 1 | 2002 | 7 | 0.210 |
Why?
|
| Immunoglobulin G | 4 | 2013 | 4546 | 0.210 |
Why?
|
| Bronchogenic Cyst | 1 | 2002 | 28 | 0.210 |
Why?
|
| Cryptococcus | 1 | 2002 | 28 | 0.210 |
Why?
|
| Tuberculosis | 1 | 2015 | 2003 | 0.210 |
Why?
|
| Genes, ras | 8 | 2009 | 654 | 0.210 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 830 | 0.210 |
Why?
|
| Brucellosis | 1 | 2002 | 21 | 0.210 |
Why?
|
| Lithiasis | 1 | 2002 | 19 | 0.210 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2002 | 41 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 704 | 0.210 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2002 | 43 | 0.200 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2015 | 800 | 0.200 |
Why?
|
| Hemosiderosis | 1 | 2002 | 66 | 0.200 |
Why?
|
| Pneumonia, Aspiration | 1 | 2003 | 146 | 0.200 |
Why?
|
| Pericardial Effusion | 1 | 2004 | 247 | 0.200 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 565 | 0.200 |
Why?
|
| Cytoplasm | 2 | 2004 | 1517 | 0.200 |
Why?
|
| Seminoma | 1 | 2003 | 134 | 0.200 |
Why?
|
| Fever of Unknown Origin | 1 | 2002 | 94 | 0.200 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2002 | 66 | 0.200 |
Why?
|
| Carotid Artery, Common | 1 | 2002 | 177 | 0.200 |
Why?
|
| Epithelium | 2 | 2006 | 1605 | 0.200 |
Why?
|
| Antibodies, Antinuclear | 1 | 2003 | 344 | 0.200 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2003 | 131 | 0.200 |
Why?
|
| Cryptococcosis | 1 | 2002 | 103 | 0.200 |
Why?
|
| Lung Transplantation | 2 | 2016 | 1304 | 0.190 |
Why?
|
| Aged, 80 and over | 31 | 2018 | 58953 | 0.190 |
Why?
|
| Temporal Arteries | 1 | 2002 | 148 | 0.190 |
Why?
|
| Granuloma, Plasma Cell | 2 | 2014 | 80 | 0.190 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2000 | 8 | 0.180 |
Why?
|
| Endophthalmitis | 1 | 2003 | 256 | 0.170 |
Why?
|
| Complement System Proteins | 1 | 2003 | 782 | 0.170 |
Why?
|
| Streptococcus pyogenes | 1 | 2002 | 294 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3333 | 0.170 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 4 | 2012 | 287 | 0.170 |
Why?
|
| Remote Consultation | 2 | 2014 | 234 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2009 | 1540 | 0.170 |
Why?
|
| Blood Chemical Analysis | 5 | 2011 | 437 | 0.170 |
Why?
|
| Chest Pain | 3 | 2014 | 1106 | 0.170 |
Why?
|
| Smoking | 14 | 2016 | 9070 | 0.160 |
Why?
|
| Mucus | 2 | 2000 | 338 | 0.160 |
Why?
|
| Carcinogens | 3 | 2010 | 449 | 0.160 |
Why?
|
| Cough | 6 | 2011 | 595 | 0.160 |
Why?
|
| Endocarditis, Bacterial | 1 | 2003 | 445 | 0.160 |
Why?
|
| Decidua | 1 | 1998 | 82 | 0.160 |
Why?
|
| Hemangioma | 2 | 2017 | 727 | 0.150 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 617 | 0.150 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2002 | 346 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 2160 | 0.150 |
Why?
|
| Phentermine | 1 | 1997 | 31 | 0.150 |
Why?
|
| Fenfluramine | 1 | 1997 | 58 | 0.150 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2011 | 129 | 0.150 |
Why?
|
| Estrogens | 1 | 2004 | 1520 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 3 | 2009 | 1570 | 0.140 |
Why?
|
| Appetite Depressants | 1 | 1997 | 108 | 0.140 |
Why?
|
| Choristoma | 1 | 1998 | 207 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4168 | 0.140 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 750 | 0.140 |
Why?
|
| Tomography, Emission-Computed | 3 | 2005 | 1121 | 0.140 |
Why?
|
| Gene Rearrangement | 2 | 2012 | 1122 | 0.140 |
Why?
|
| Testicular Neoplasms | 1 | 2003 | 800 | 0.140 |
Why?
|
| Hyperplasia | 7 | 2015 | 1158 | 0.140 |
Why?
|
| Bone Marrow | 2 | 2002 | 2918 | 0.140 |
Why?
|
| Neoplasm Staging | 13 | 2019 | 11141 | 0.140 |
Why?
|
| Cause of Death | 1 | 2007 | 3723 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 1919 | 0.130 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 1097 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2012 | 2500 | 0.130 |
Why?
|
| Failure to Thrive | 1 | 2017 | 140 | 0.130 |
Why?
|
| Genes, erbB-1 | 2 | 2007 | 160 | 0.130 |
Why?
|
| Echocardiography | 4 | 2017 | 4980 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 1999 | 291 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2202 | 0.130 |
Why?
|
| Shock, Septic | 1 | 2002 | 760 | 0.130 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 1006 | 0.130 |
Why?
|
| Tracheitis | 1 | 2015 | 29 | 0.130 |
Why?
|
| Eosinophilic Granuloma | 2 | 2002 | 27 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 816 | 0.130 |
Why?
|
| Actinomyces | 1 | 2015 | 40 | 0.130 |
Why?
|
| Vision Disorders | 1 | 2003 | 1084 | 0.130 |
Why?
|
| Mediastinum | 2 | 2009 | 265 | 0.130 |
Why?
|
| Physical Exertion | 2 | 2008 | 662 | 0.130 |
Why?
|
| Bronchiectasis | 2 | 2016 | 138 | 0.130 |
Why?
|
| Heart Septum | 1 | 2016 | 303 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 6 | 2016 | 1705 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2004 | 1905 | 0.120 |
Why?
|
| Leukopenia | 1 | 2015 | 212 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9196 | 0.120 |
Why?
|
| Immunodominant Epitopes | 1 | 2016 | 241 | 0.120 |
Why?
|
| Heparin | 1 | 2002 | 1656 | 0.120 |
Why?
|
| Laryngostenosis | 2 | 1993 | 167 | 0.120 |
Why?
|
| Carcinoid Tumor | 3 | 1991 | 228 | 0.120 |
Why?
|
| Cytodiagnosis | 2 | 2016 | 432 | 0.120 |
Why?
|
| beta Catenin | 3 | 2004 | 1043 | 0.120 |
Why?
|
| Pulmonary Artery | 3 | 2008 | 1919 | 0.120 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2016 | 311 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2002 | 1174 | 0.120 |
Why?
|
| Asbestos, Amphibole | 1 | 2013 | 7 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2010 | 1828 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 1484 | 0.110 |
Why?
|
| Diagnostic Imaging | 3 | 2014 | 3526 | 0.110 |
Why?
|
| Pyridones | 1 | 2019 | 788 | 0.110 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 275 | 0.110 |
Why?
|
| Pneumothorax | 3 | 2007 | 377 | 0.110 |
Why?
|
| Sputum | 3 | 2012 | 503 | 0.110 |
Why?
|
| Growth Disorders | 2 | 2017 | 654 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 378 | 0.110 |
Why?
|
| Prognosis | 16 | 2016 | 29640 | 0.110 |
Why?
|
| Travel | 3 | 2004 | 786 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2012 | 2415 | 0.110 |
Why?
|
| Simian virus 40 | 1 | 2013 | 291 | 0.110 |
Why?
|
| Nasal Mucosa | 1 | 1996 | 413 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 6067 | 0.110 |
Why?
|
| Aortic Valve | 1 | 2003 | 1998 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 3870 | 0.100 |
Why?
|
| Lymphatic Metastasis | 6 | 2016 | 2945 | 0.100 |
Why?
|
| Myocardium | 2 | 2002 | 4687 | 0.100 |
Why?
|
| Edema | 2 | 2016 | 772 | 0.100 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2012 | 20 | 0.100 |
Why?
|
| Atrial Appendage | 1 | 2016 | 292 | 0.100 |
Why?
|
| Iran | 2 | 2013 | 734 | 0.100 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2014 | 167 | 0.100 |
Why?
|
| Microscopy | 4 | 2014 | 881 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2011 | 42 | 0.100 |
Why?
|
| Esophageal Diseases | 1 | 2012 | 168 | 0.100 |
Why?
|
| Sweating | 2 | 2003 | 154 | 0.100 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 121 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2010 | 1591 | 0.100 |
Why?
|
| Headache | 4 | 2002 | 1249 | 0.100 |
Why?
|
| Leg | 3 | 2016 | 1091 | 0.100 |
Why?
|
| Hematologic Tests | 2 | 2002 | 238 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2002 | 832 | 0.100 |
Why?
|
| Ligases | 1 | 2012 | 332 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2014 | 2007 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2013 | 262 | 0.090 |
Why?
|
| Hemorrhage | 4 | 1993 | 3606 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1810 | 0.090 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2011 | 47 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2001 | 2927 | 0.090 |
Why?
|
| Thoracic Diseases | 1 | 2012 | 98 | 0.090 |
Why?
|
| Eyelid Diseases | 1 | 2012 | 157 | 0.090 |
Why?
|
| Indoles | 1 | 2019 | 1830 | 0.090 |
Why?
|
| Respiratory System Abnormalities | 1 | 2011 | 67 | 0.090 |
Why?
|
| Bronchiolitis | 2 | 2012 | 479 | 0.090 |
Why?
|
| Mycobacterium | 1 | 2012 | 250 | 0.090 |
Why?
|
| Capillaries | 3 | 2005 | 745 | 0.090 |
Why?
|
| Endoderm | 2 | 1990 | 155 | 0.090 |
Why?
|
| Endometriosis | 1 | 1998 | 871 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2012 | 5640 | 0.090 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 270 | 0.090 |
Why?
|
| DNA Mutational Analysis | 6 | 2016 | 4110 | 0.090 |
Why?
|
| Metabolomics | 1 | 2019 | 1626 | 0.090 |
Why?
|
| Thrombosis | 2 | 2002 | 3053 | 0.090 |
Why?
|
| Mediastinal Diseases | 2 | 2009 | 91 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 827 | 0.090 |
Why?
|
| Professional Role | 1 | 2012 | 311 | 0.090 |
Why?
|
| Keratin-7 | 1 | 2009 | 55 | 0.080 |
Why?
|
| Child | 13 | 2015 | 79759 | 0.080 |
Why?
|
| Dermatomyositis | 1 | 2012 | 256 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1416 | 0.080 |
Why?
|
| Staining and Labeling | 2 | 2012 | 1090 | 0.080 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2009 | 113 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 3 | 2001 | 416 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4494 | 0.080 |
Why?
|
| Hamartoma | 2 | 2013 | 235 | 0.080 |
Why?
|
| DNA, Neoplasm | 4 | 2007 | 1745 | 0.080 |
Why?
|
| Mucins | 2 | 1999 | 569 | 0.080 |
Why?
|
| Chronic Disease | 4 | 2016 | 9287 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4577 | 0.080 |
Why?
|
| DNA Damage | 4 | 2001 | 2442 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1483 | 0.080 |
Why?
|
| Genes, p53 | 4 | 2001 | 714 | 0.080 |
Why?
|
| Leukemoid Reaction | 1 | 1988 | 18 | 0.080 |
Why?
|
| Polyradiculoneuropathy | 1 | 2008 | 65 | 0.080 |
Why?
|
| Lung Abscess | 1 | 2008 | 41 | 0.080 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2010 | 165 | 0.080 |
Why?
|
| Arthralgia | 1 | 2012 | 461 | 0.080 |
Why?
|
| Acrosome Reaction | 1 | 2008 | 7 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2009 | 373 | 0.080 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2008 | 107 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 563 | 0.080 |
Why?
|
| Histiocytes | 1 | 2008 | 98 | 0.080 |
Why?
|
| Sperm Capacitation | 1 | 2008 | 21 | 0.080 |
Why?
|
| Sepsis | 1 | 2002 | 2594 | 0.080 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1988 | 63 | 0.080 |
Why?
|
| Serum | 1 | 2009 | 211 | 0.080 |
Why?
|
| Aspergillus | 1 | 2008 | 92 | 0.080 |
Why?
|
| Infant | 6 | 2017 | 36032 | 0.070 |
Why?
|
| West Indies | 2 | 2002 | 33 | 0.070 |
Why?
|
| Soft Tissue Injuries | 1 | 2009 | 172 | 0.070 |
Why?
|
| Fibrosis | 3 | 2008 | 2041 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2013 | 517 | 0.070 |
Why?
|
| Esophageal Stenosis | 1 | 2009 | 193 | 0.070 |
Why?
|
| Plasma Cell Granuloma, Pulmonary | 1 | 2007 | 12 | 0.070 |
Why?
|
| Factor XIIIa | 1 | 2007 | 10 | 0.070 |
Why?
|
| Mediastinal Emphysema | 1 | 2007 | 29 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 697 | 0.070 |
Why?
|
| Fibroma | 1 | 1989 | 190 | 0.070 |
Why?
|
| Acute Disease | 3 | 2008 | 7268 | 0.070 |
Why?
|
| Vertigo | 1 | 2009 | 202 | 0.070 |
Why?
|
| Brain | 2 | 2017 | 26905 | 0.070 |
Why?
|
| Horses | 1 | 2008 | 299 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2012 | 2118 | 0.070 |
Why?
|
| Lymphography | 2 | 2002 | 188 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2016 | 1300 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2011 | 859 | 0.070 |
Why?
|
| Mustard Gas | 1 | 2006 | 8 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 7 | 2014 | 3619 | 0.070 |
Why?
|
| Chemical Warfare Agents | 1 | 2006 | 19 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2014 | 3333 | 0.070 |
Why?
|
| Eye Diseases | 2 | 2002 | 651 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 4286 | 0.070 |
Why?
|
| Retrospective Studies | 14 | 2018 | 80311 | 0.070 |
Why?
|
| Lymphoma | 3 | 2005 | 1899 | 0.070 |
Why?
|
| History, 15th Century | 1 | 2006 | 29 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2006 | 5867 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2002 | 4899 | 0.070 |
Why?
|
| History, Medieval | 1 | 2006 | 62 | 0.070 |
Why?
|
| Albuterol | 1 | 2007 | 212 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1992 | 810 | 0.070 |
Why?
|
| History, 16th Century | 1 | 2006 | 70 | 0.070 |
Why?
|
| Muscle Weakness | 1 | 2009 | 413 | 0.060 |
Why?
|
| Culture Media | 1 | 2008 | 899 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2804 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2007 | 345 | 0.060 |
Why?
|
| History, Ancient | 1 | 2006 | 211 | 0.060 |
Why?
|
| Arteries | 2 | 2002 | 1126 | 0.060 |
Why?
|
| Placenta | 1 | 1995 | 1701 | 0.060 |
Why?
|
| Disease Progression | 4 | 2018 | 13503 | 0.060 |
Why?
|
| Amenorrhea | 1 | 2009 | 480 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2002 | 4312 | 0.060 |
Why?
|
| Necrosis | 3 | 2014 | 1612 | 0.060 |
Why?
|
| Genotype | 5 | 2012 | 12959 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 1975 | 0.060 |
Why?
|
| Folic Acid | 1 | 2012 | 1309 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 441 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2009 | 951 | 0.060 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2012 | 85 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 3764 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 8935 | 0.060 |
Why?
|
| Intestines | 1 | 2014 | 1908 | 0.060 |
Why?
|
| Survival Rate | 7 | 2016 | 12806 | 0.060 |
Why?
|
| Lymphoid Tissue | 2 | 1985 | 446 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2001 | 749 | 0.060 |
Why?
|
| Tissue Array Analysis | 2 | 2016 | 551 | 0.060 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2004 | 62 | 0.060 |
Why?
|
| Pericardiocentesis | 1 | 2004 | 79 | 0.060 |
Why?
|
| Prednisone | 1 | 2009 | 1566 | 0.060 |
Why?
|
| Lymphatic System | 2 | 2002 | 254 | 0.060 |
Why?
|
| Adolescent | 17 | 2016 | 87749 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2008 | 358 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2008 | 560 | 0.060 |
Why?
|
| Treatment Refusal | 1 | 2007 | 430 | 0.060 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2004 | 135 | 0.060 |
Why?
|
| Inflammation | 2 | 2015 | 10758 | 0.060 |
Why?
|
| Sarcoma | 2 | 1999 | 1786 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 4391 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 2004 | 206 | 0.060 |
Why?
|
| Coronary Disease | 2 | 2012 | 5993 | 0.060 |
Why?
|
| Carcinosarcoma | 1 | 2004 | 104 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2008 | 631 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8487 | 0.060 |
Why?
|
| Hypergammaglobulinemia | 1 | 2003 | 72 | 0.060 |
Why?
|
| Fibroblasts | 4 | 2007 | 4089 | 0.060 |
Why?
|
| Biopsy, Needle | 3 | 2013 | 1633 | 0.060 |
Why?
|
| Estrogen Receptor beta | 1 | 2004 | 168 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2017 | 36230 | 0.050 |
Why?
|
| Neoplasms | 3 | 2015 | 22066 | 0.050 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2002 | 8 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5120 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2004 | 574 | 0.050 |
Why?
|
| Myeloproliferative Disorders | 1 | 2009 | 612 | 0.050 |
Why?
|
| Diagnostic Errors | 2 | 2009 | 1266 | 0.050 |
Why?
|
| Hand | 1 | 1988 | 903 | 0.050 |
Why?
|
| Legionnaires' Disease | 1 | 2003 | 49 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 627 | 0.050 |
Why?
|
| Heartburn | 1 | 2003 | 68 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 174 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2007 | 566 | 0.050 |
Why?
|
| Thymus Hyperplasia | 1 | 2003 | 32 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8058 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 489 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2277 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1991 | 2197 | 0.050 |
Why?
|
| Face | 1 | 2009 | 1017 | 0.050 |
Why?
|
| Carcinoma | 2 | 1991 | 2334 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2006 | 304 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2006 | 347 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11708 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2009 | 1505 | 0.050 |
Why?
|
| Tongue Diseases | 1 | 2002 | 68 | 0.050 |
Why?
|
| Sacroiliac Joint | 1 | 2002 | 57 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 444 | 0.050 |
Why?
|
| Superinfection | 1 | 2002 | 64 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2009 | 6546 | 0.050 |
Why?
|
| Immune Complex Diseases | 1 | 1981 | 52 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2009 | 1183 | 0.050 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2002 | 79 | 0.050 |
Why?
|
| Pneumoconiosis | 1 | 1981 | 32 | 0.050 |
Why?
|
| Doxycycline | 1 | 2003 | 337 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 1166 | 0.050 |
Why?
|
| Epistaxis | 1 | 2002 | 111 | 0.050 |
Why?
|
| Heart Defects, Congenital | 2 | 2017 | 4668 | 0.050 |
Why?
|
| Endometrium | 1 | 2004 | 403 | 0.050 |
Why?
|
| Ribavirin | 1 | 2003 | 396 | 0.050 |
Why?
|
| Phenols | 1 | 2005 | 513 | 0.050 |
Why?
|
| Paralysis | 1 | 2002 | 251 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2003 | 281 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2002 | 151 | 0.050 |
Why?
|
| Graves Disease | 1 | 2002 | 239 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9274 | 0.050 |
Why?
|
| Infarction | 1 | 2002 | 248 | 0.050 |
Why?
|
| Genes, p16 | 1 | 2001 | 159 | 0.050 |
Why?
|
| Cellulitis | 1 | 2002 | 208 | 0.050 |
Why?
|
| Tachycardia | 1 | 2003 | 603 | 0.040 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2000 | 64 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2013 | 22040 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2016 | 12100 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 1328 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2011 | 8551 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 409 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2002 | 308 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2009 | 4002 | 0.040 |
Why?
|
| Urinalysis | 1 | 2002 | 368 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2001 | 313 | 0.040 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 426 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1983 | 533 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2008 | 912 | 0.040 |
Why?
|
| Vacuoles | 1 | 2000 | 229 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2018 | 8553 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1411 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2805 | 0.040 |
Why?
|
| Peptides | 1 | 1991 | 4357 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2006 | 1045 | 0.040 |
Why?
|
| Cerebral Arteries | 1 | 2002 | 493 | 0.040 |
Why?
|
| Peru | 1 | 2002 | 870 | 0.040 |
Why?
|
| ras Proteins | 2 | 2016 | 1051 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1799 | 0.040 |
Why?
|
| Carcinogens, Environmental | 1 | 1999 | 72 | 0.040 |
Why?
|
| DNA Repair | 3 | 2010 | 2039 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2002 | 592 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2003 | 919 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 1981 | 213 | 0.040 |
Why?
|
| Hepatic Veins | 1 | 1999 | 111 | 0.040 |
Why?
|
| Mycoses | 1 | 2002 | 387 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2002 | 562 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3207 | 0.040 |
Why?
|
| Arthritis, Infectious | 1 | 2002 | 345 | 0.040 |
Why?
|
| Heart Failure | 1 | 2003 | 11836 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2015 | 20045 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 659 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6457 | 0.040 |
Why?
|
| Back Pain | 1 | 2002 | 543 | 0.040 |
Why?
|
| Endocarditis | 1 | 2002 | 351 | 0.040 |
Why?
|
| Embolism, Cholesterol | 1 | 1997 | 33 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2002 | 718 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2019 | 10185 | 0.040 |
Why?
|
| Endothelium | 2 | 2003 | 764 | 0.040 |
Why?
|
| Neck | 1 | 2002 | 730 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2008 | 4127 | 0.040 |
Why?
|
| Young Adult | 6 | 2016 | 58673 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2558 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2000 | 561 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2777 | 0.040 |
Why?
|
| Valine | 1 | 2019 | 409 | 0.040 |
Why?
|
| Cocarcinogenesis | 2 | 1999 | 49 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2003 | 1189 | 0.040 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 222 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2003 | 732 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2003 | 1206 | 0.040 |
Why?
|
| Pain | 2 | 2002 | 5066 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 4357 | 0.040 |
Why?
|
| Occupational Exposure | 2 | 1999 | 1810 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2007 | 1506 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 2000 | 377 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2001 | 4374 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2003 | 1108 | 0.030 |
Why?
|
| General Surgery | 1 | 2008 | 1681 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2007 | 2522 | 0.030 |
Why?
|
| Pulmonary Embolism | 2 | 2002 | 2544 | 0.030 |
Why?
|
| Teratoma | 1 | 1999 | 403 | 0.030 |
Why?
|
| Homeostasis | 1 | 2007 | 3305 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 1988 | 2532 | 0.030 |
Why?
|
| Rare Diseases | 2 | 2012 | 619 | 0.030 |
Why?
|
| Observer Variation | 2 | 2014 | 2596 | 0.030 |
Why?
|
| Glutamine | 1 | 2019 | 576 | 0.030 |
Why?
|
| Somatostatin | 1 | 1998 | 447 | 0.030 |
Why?
|
| Seizures | 1 | 2009 | 2916 | 0.030 |
Why?
|
| Glycine | 1 | 2019 | 663 | 0.030 |
Why?
|
| Respiration | 1 | 2002 | 1648 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5230 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 1998 | 631 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2002 | 1064 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3564 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8502 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1999 | 586 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 2880 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2003 | 1240 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2002 | 1130 | 0.030 |
Why?
|
| Risk Factors | 6 | 2012 | 74278 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2000 | 854 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2009 | 11894 | 0.030 |
Why?
|
| Gene Expression | 2 | 2001 | 7592 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 332 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1995 | 348 | 0.030 |
Why?
|
| Mouth Neoplasms | 1 | 1999 | 593 | 0.030 |
Why?
|
| Base Sequence | 2 | 2002 | 12447 | 0.030 |
Why?
|
| Laminin | 1 | 1995 | 405 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2000 | 2609 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2002 | 1089 | 0.030 |
Why?
|
| Boston | 1 | 2006 | 9283 | 0.030 |
Why?
|
| Quinazolines | 2 | 2011 | 1363 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 2047 | 0.030 |
Why?
|
| Minnesota | 1 | 2014 | 340 | 0.030 |
Why?
|
| Syncope | 1 | 2016 | 428 | 0.030 |
Why?
|
| Metalloporphyrins | 1 | 1993 | 40 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 2633 | 0.030 |
Why?
|
| Treatment Outcome | 7 | 2014 | 64968 | 0.030 |
Why?
|
| von Willebrand Factor | 2 | 1995 | 673 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2008 | 8523 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2001 | 5784 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2017 | 3903 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 2274 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2010 | 1790 | 0.030 |
Why?
|
| Glomerulonephritis | 1 | 2014 | 337 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2001 | 12763 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 1999 | 1267 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 1996 | 490 | 0.020 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 1991 | 37 | 0.020 |
Why?
|
| Keratins | 2 | 1991 | 497 | 0.020 |
Why?
|
| Histoplasma | 1 | 1991 | 39 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 1992 | 65 | 0.020 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2012 | 83 | 0.020 |
Why?
|
| Pregnancy | 4 | 2004 | 29727 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 697 | 0.020 |
Why?
|
| Pyrazoles | 2 | 2012 | 1992 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1997 | 2024 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 13629 | 0.020 |
Why?
|
| Data Display | 1 | 2012 | 174 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 1989 | 5324 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15765 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 279 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 15272 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1090 | 0.020 |
Why?
|
| Monocytes | 1 | 2000 | 2574 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2003 | 3061 | 0.020 |
Why?
|
| Stents | 1 | 2003 | 3306 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 1274 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1992 | 227 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2001 | 330 | 0.020 |
Why?
|
| Time Factors | 6 | 2012 | 40141 | 0.020 |
Why?
|
| Pyridines | 2 | 2012 | 2877 | 0.020 |
Why?
|
| Western World | 1 | 2009 | 26 | 0.020 |
Why?
|
| Computer Communication Networks | 1 | 2012 | 294 | 0.020 |
Why?
|
| Workflow | 1 | 2014 | 851 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2012 | 367 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2016 | 818 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 717 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2011 | 387 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1955 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2011 | 410 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39256 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2009 | 271 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 9590 | 0.020 |
Why?
|
| Larynx | 1 | 1993 | 492 | 0.020 |
Why?
|
| Proteins | 2 | 2001 | 6030 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2014 | 688 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2008 | 100 | 0.020 |
Why?
|
| Bucladesine | 1 | 2008 | 118 | 0.020 |
Why?
|
| Asthma | 1 | 2007 | 6167 | 0.020 |
Why?
|
| Phenotype | 3 | 2012 | 16543 | 0.020 |
Why?
|
| Calcimycin | 1 | 2008 | 213 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3665 | 0.020 |
Why?
|
| Ionophores | 1 | 2008 | 107 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 3223 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2002 | 3128 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2008 | 204 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 1993 | 785 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 197 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3450 | 0.020 |
Why?
|
| Arterioles | 1 | 2008 | 250 | 0.020 |
Why?
|
| Leukocytes | 1 | 1996 | 2030 | 0.020 |
Why?
|
| Endonucleases | 1 | 2010 | 370 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1993 | 903 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1991 | 1900 | 0.020 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2007 | 34 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1993 | 1229 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 21379 | 0.020 |
Why?
|
| DNA | 2 | 2005 | 7236 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1999 | 3112 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1992 | 1064 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14655 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2008 | 323 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2002 | 4320 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9497 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2008 | 304 | 0.020 |
Why?
|
| Collagen | 1 | 1995 | 2635 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2007 | 156 | 0.020 |
Why?
|
| CpG Islands | 2 | 2001 | 1221 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 317 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2007 | 362 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2052 | 0.020 |
Why?
|
| Precancerous Conditions | 2 | 1983 | 978 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 1161 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1996 | 1651 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2001 | 1135 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2008 | 932 | 0.020 |
Why?
|
| Physical Examination | 1 | 2011 | 1244 | 0.020 |
Why?
|
| Hypertension | 1 | 2005 | 8595 | 0.020 |
Why?
|
| Acyclovir | 1 | 1986 | 269 | 0.020 |
Why?
|
| Silicosis | 1 | 1985 | 47 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2363 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1344 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 2434 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2005 | 363 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1986 | 270 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4044 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2008 | 1649 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2009 | 1870 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2008 | 610 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2011 | 1013 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2009 | 929 | 0.010 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 2014 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1999 | 4404 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 1985 | 180 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2002 | 42036 | 0.010 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2005 | 180 | 0.010 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 1983 | 16 | 0.010 |
Why?
|
| Aorta | 1 | 1992 | 2042 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5201 | 0.010 |
Why?
|
| Animals | 8 | 2013 | 167935 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 1246 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1455 | 0.010 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 1983 | 40 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3618 | 0.010 |
Why?
|
| Equipment Design | 1 | 2012 | 3521 | 0.010 |
Why?
|
| Progesterone | 1 | 2008 | 742 | 0.010 |
Why?
|
| Inhalation Exposure | 1 | 2006 | 429 | 0.010 |
Why?
|
| Tyrosine | 1 | 2008 | 1440 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1078 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3829 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2007 | 1577 | 0.010 |
Why?
|
| Exons | 2 | 1999 | 2391 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1991 | 1999 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1983 | 2823 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 995 | 0.010 |
Why?
|
| Immunoglobulin A | 2 | 1986 | 978 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4554 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1838 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2007 | 1218 | 0.010 |
Why?
|
| Swine | 1 | 2013 | 5902 | 0.010 |
Why?
|
| Age Factors | 3 | 2009 | 18416 | 0.010 |
Why?
|
| Atherectomy, Coronary | 1 | 2003 | 146 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1988 | 1112 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12159 | 0.010 |
Why?
|
| Neurosecretion | 1 | 1982 | 10 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6830 | 0.010 |
Why?
|
| Ephedrine | 1 | 2002 | 52 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1408 | 0.010 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 1111 | 0.010 |
Why?
|
| Kaolin | 1 | 1981 | 16 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2002 | 127 | 0.010 |
Why?
|
| Neostigmine | 1 | 1981 | 68 | 0.010 |
Why?
|
| Aluminum Silicates | 1 | 1981 | 24 | 0.010 |
Why?
|
| Sjogren's Syndrome | 1 | 1983 | 235 | 0.010 |
Why?
|
| Beryllium | 1 | 1981 | 14 | 0.010 |
Why?
|
| Mice, Nude | 2 | 2002 | 3605 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 2753 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1982 | 230 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 1984 | 376 | 0.010 |
Why?
|
| Silver | 1 | 1982 | 120 | 0.010 |
Why?
|
| Sex Factors | 2 | 2009 | 10529 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 2005 | 453 | 0.010 |
Why?
|
| Talc | 1 | 1981 | 48 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2009 | 1843 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1956 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 915 | 0.010 |
Why?
|
| Software | 1 | 2014 | 4419 | 0.010 |
Why?
|
| Sister Chromatid Exchange | 1 | 2000 | 60 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 17766 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2002 | 565 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4276 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2000 | 104 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1993 | 2332 | 0.010 |
Why?
|
| Regression Analysis | 2 | 1999 | 6361 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2007 | 1534 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 674 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1999 | 115 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1982 | 575 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 25927 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2002 | 374 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1985 | 1015 | 0.010 |
Why?
|
| Codon | 1 | 2001 | 602 | 0.010 |
Why?
|
| Sclerosis | 1 | 1999 | 210 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2002 | 23366 | 0.010 |
Why?
|
| Choroid Plexus | 1 | 1981 | 237 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 1155 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 2145 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1999 | 761 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1981 | 568 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2014 | 54265 | 0.010 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1999 | 137 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2001 | 786 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2001 | 4891 | 0.010 |
Why?
|
| United States | 1 | 2006 | 72369 | 0.010 |
Why?
|
| Autoradiography | 1 | 1999 | 730 | 0.010 |
Why?
|
| Pneumonectomy | 2 | 1999 | 1110 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2002 | 651 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1999 | 274 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 698 | 0.010 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1997 | 41 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2003 | 1246 | 0.010 |
Why?
|
| Mitosis | 2 | 1999 | 1193 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1616 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 1999 | 507 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 2005 | 1381 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2008 | 2978 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3483 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1982 | 1529 | 0.010 |
Why?
|
| Logistic Models | 1 | 2012 | 13315 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1999 | 635 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1981 | 2473 | 0.010 |
Why?
|
| Education, Medical | 1 | 1989 | 1728 | 0.010 |
Why?
|
| Rabbits | 1 | 1983 | 4773 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 3531 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1999 | 26169 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8314 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24086 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 1036 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4462 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9530 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 1295 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3537 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2730 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 2819 | 0.010 |
Why?
|
| Smoking Cessation | 2 | 1999 | 2064 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 1996 | 180 | 0.010 |
Why?
|
| Hydrocarbons | 1 | 1995 | 105 | 0.010 |
Why?
|
| Gingival Diseases | 1 | 1995 | 36 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2001 | 1511 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 1862 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1999 | 1008 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1995 | 173 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2002 | 2208 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6131 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2852 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15828 | 0.010 |
Why?
|
| Cicatrix | 1 | 1999 | 781 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6543 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2003 | 1578 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1999 | 1770 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10439 | 0.010 |
Why?
|
| Orbital Diseases | 1 | 1995 | 178 | 0.010 |
Why?
|
| Myeloblastin | 1 | 1993 | 101 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1981 | 1870 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 815 | 0.010 |
Why?
|
| Clone Cells | 1 | 1996 | 1663 | 0.010 |
Why?
|
| Churg-Strauss Syndrome | 1 | 1993 | 74 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 1999 | 933 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 5746 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1996 | 1056 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1995 | 443 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1999 | 2612 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1989 | 5395 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1999 | 1748 | 0.010 |
Why?
|
| Mice | 3 | 2008 | 81212 | 0.010 |
Why?
|
| Physicians | 1 | 1989 | 4590 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4561 | 0.010 |
Why?
|
| Arteritis | 1 | 1993 | 162 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1999 | 2525 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 2931 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 22026 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 1997 | 1113 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1991 | 143 | 0.010 |
Why?
|
| Manganese | 1 | 1993 | 395 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11481 | 0.010 |
Why?
|
| Peroxidase | 1 | 1993 | 604 | 0.010 |
Why?
|
| Heterozygote | 1 | 1996 | 2797 | 0.010 |
Why?
|
| Skin | 1 | 1981 | 4467 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1993 | 1021 | 0.000 |
Why?
|
| Thyroid Gland | 1 | 1993 | 1169 | 0.000 |
Why?
|
| Aging | 1 | 1985 | 8641 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3806 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 9390 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1989 | 657 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1986 | 650 | 0.000 |
Why?
|
| Models, Statistical | 1 | 1999 | 5072 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1985 | 693 | 0.000 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1985 | 336 | 0.000 |
Why?
|
| Vinblastine | 1 | 1984 | 487 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1984 | 373 | 0.000 |
Why?
|
| Factor VIII | 1 | 1985 | 350 | 0.000 |
Why?
|
| Prevalence | 1 | 1999 | 15684 | 0.000 |
Why?
|
| Cholesterol | 1 | 1991 | 2925 | 0.000 |
Why?
|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 1981 | 13 | 0.000 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1981 | 69 | 0.000 |
Why?
|
| Somatomedins | 1 | 1981 | 178 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1986 | 1075 | 0.000 |
Why?
|
| Image Enhancement | 1 | 1991 | 2877 | 0.000 |
Why?
|
| Contrast Media | 1 | 1993 | 5300 | 0.000 |
Why?
|
| Antigens | 1 | 1985 | 1447 | 0.000 |
Why?
|
| Virus Replication | 1 | 1986 | 2431 | 0.000 |
Why?
|
| Thyroid Hormones | 1 | 1981 | 403 | 0.000 |
Why?
|
| Hyperinsulinism | 1 | 1981 | 398 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1984 | 2207 | 0.000 |
Why?
|
| Pituitary-Adrenal System | 1 | 1981 | 550 | 0.000 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1981 | 698 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3145 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1981 | 1798 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1981 | 6375 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 21065 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1984 | 8980 | 0.000 |
Why?
|